| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2023―Aug―27 |
Risk of Arterial Hypertension After COVID-19 Recovery |
Tomoyuki Kawada |
| 2 |
[GO] |
2023―Mai―12 |
Discontinuation of Antihypertensive Drug Use Compared to Continuation in COVID-19 Patients: A Systematic Review with Meta-analysis and Trial Sequential Analysis |
Diego Chambergo-Michilot, Fernando M. Runzer-Colmenares, Pedro A. Segura-Saldaña |
| 3 |
[GO] |
2023―Apr―15 |
Risk of Incident New-Onset Arterial Hypertension After COVID-19 Recovery: A Systematic Review and Meta-analysis |
Marco Zuin, Gianluca Rigatelli, Claudio Bilato, Giampaolo Pasquetto, Alberto Mazza |
| 4 |
[GO] |
2022―Mai―17 |
Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience |
Saula Vigili de Kreutzenberg |
| 5 |
[GO] |
2022―Mrz―17 |
Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19 |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 6 |
[GO] |
2022―Mrz―08 |
COVID-19 Vaccination in Hemodialysis Patients Correspondence |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 7 |
[GO] |
2022―Feb―20 |
Hypertension and COVID-19: Current Evidence and Perspectives |
Giovanna Gallo, Valentin Calvez, Carmine Savoia |
| 8 |
[GO] |
2022―Jan―03 |
Humoral Immune Response to COVID-19 Vaccination in Hemodialysis Patients: A Retrospective, Observational Case-Control Pilot Study |
Luca Piscitani, Rita Del Pinto, Andrea Basili, Marilena Tunno, Claudio Ferri |
| 9 |
[GO] |
2021―Dez―02 |
Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic |
Barbara Citoni, Ilaria Figliuzzi, Vivianne Presta, Massimo Volpe, Giuliano Tocci |
| 10 |
[GO] |
2021―Aug―18 |
Blood Pressure and Lipid Profile in Hypertensive Patients Post the First COVID-19 Lockdown: “Brief Letter for Publication” |
Ilaria Fucile, Maria Virginia Manzi, Costantino Mancusi |
| 11 |
[GO] |
2021―Jun―28 |
Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population |
Yasar Sattar, Pradeeksha Mukuntharaj, Mohamed Zghouzi, Abdul-Rahman M. Suleiman, Hassan Attique, Waqas Ullah, et al. (+13) Muhammad Khawar Sana, Nathan Zaher, Maham Mehmood, Rajkumar P. Doshi, Ankur Panchal, Tanveer Mir, Muhammad Nadeem, Omar E. Ali, Mohamad Mohamed, Rodrigo Bagur, Islam Y. Elgendy, Mamas A. Mamas, M. Chadi Alraies |
| 12 |
[GO] |
2021―Apr―28 |
Short-Term Consequences of SARS-CoV-2-Related Pneumonia: A Follow Up Study |
Gianluca E. M. Boari, Silvia Bonetti, Federico Braglia-Orlandini, Giulia Chiarini, Cristina Faustini, Gianluca Bianco, et al. (+13) Marzia Santagiuliana, Vittoria Guarinoni, Michele Saottini, Sara Viola, Giulia Ferrari-Toninelli, Giancarlo Pasini, Bianca Bonzi, Paolo Desenzani, Claudia Tusi, Paolo Malerba, Eros Zanotti, Daniele Turini, Damiano Rizzoni |
| 13 |
[GO] |
2021―Apr―27 |
Role of Statins in Coronavirus-Related Disease (COVID-19): A Retrospective Cohort Study in Northern Italy |
Salvatore Greco, Andrea D’Amuri, Enrico Giorgini, Francesco Luciani, Mariarosaria Lopreiato, Valeria Fortunato, et al. (+4) Alessandro Scopa, Grazia Vestita, Eleonora Capatti, Angelina Passaro |
| 14 |
[GO] |
2021―Apr―26 |
A Plea for Smoking-Free Policies in COVID-19 Times: Cardiovascular Prevention as an Ally in Coronavirus Containment |
Giacomo Tini, Giovanna Gallo, Beatrice Musumeci, Giuliano Tocci, Massimo Volpe |
| 15 |
[GO] |
2021―Apr―01 |
Commentary to Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update |
Claudio Ferri, Giovambattista Desideri, Rita Del Pinto |
| 16 |
[GO] |
2021―Mrz―12 |
ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients |
Vivianne Presta, Ilaria Figliuzzi, Barbara Citoni, Giovanna Gallo, Allegra Battistoni, Giuliano Tocci, Massimo Volpe |
| 17 |
[GO] |
2021―Feb―26 |
Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update |
Ashwin Kumar Shukla, Monisha Banerjee |
| 18 |
[GO] |
2021―Jan―20 |
Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension |
Costantino Mancusi, Guido Grassi, Claudio Borghi, Claudio Ferri, Maria Lorenza Muiesan, Massimo Volpe, Guido Iaccarino |
| 19 |
[GO] |
2020―Sep―19 |
Impact of Treatment with Renin-Angiotensin System Inhibitors on Clinical Outcomes in Hypertensive Patients Hospitalized with COVID-19 |
Martin Negreira-Caamaño, Jesus Piqueras-Flores, Jorge Martínez-DelRio, Patricia Nieto-Sandoval-Martin-DeLaSierra, Daniel Aguila-Gordo, Cristina Mateo-Gomez, et al. (+3) Daniel Salas-Bravo, Marta Rodriguez-Martinez, Martín Negreira-Caamaño |
| 20 |
[GO] |
2020―Aug―29 |
COVID-19 and the Forgotten Majority |
Massimo Volpe, Giovanna Gallo |
| 21 |
[GO] |
2020―Jul―30 |
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention |
Massimo Volpe, Allegra Battistoni, Paolo Bellotti, Simonetta Bellone, Marco Bertolotti, Alessandro Biffi, et al. (+12) Agostino Consoli, Alberto Corsini, Giovambattista Desideri, Claudio Ferri, Maria Grazia Modena, Giulio Nati, Matteo Pirro, Speranza Rubattu, Giuliano Tocci, Bruno Trimarco, Roberto Volpe, Saula Vigili de Kreutzenberg |
